Literature DB >> 14563380

The distribution and morphology of prefrontal cortex pyramidal neurons identified using anti-neurofilament antibodies SMI32, N200 and FNP7. Normative data and a comparison in subjects with schizophrenia, bipolar disorder or major depression.

Amanda J Law1, Paul J Harrison.   

Abstract

Alterations in the density and size of pyramidal neurons in the prefrontal cortex have been described in schizophrenia and mood disorder. However, the changes are generally modest and have not always been replicated. We investigated the possibility that specific pyramidal neuron sub-populations, defined by their immunoreactivity with the anti-neurofilament antibodies SMI32, N200, and FNP7, are differentially affected in these disorders. First, we assessed the distribution and characteristics of pyramidal neurons labelled by the antibodies in the human dorsolateral prefrontal cortex (Brodmann areas 9, 32, 46), using single and double label immunocytochemistry and immunofluorescence. Three largely separate sub-populations of pyramidal neurons were identified, although with more substantial overlap between SMI32- and FNP7-positive neurons in lamina V. We then determined the density, size and shape of the three pyramidal neuron sub-populations in area 9 in patients with schizophrenia, bipolar disorder, or major depressive disorder, compared to controls (n=15 in each group). We found a lower density of lamina III N200-positive neurons in major depressive disorder than in schizophrenia or bipolar disorder. There were no other overall differences in neuronal density, or in neuronal size or shape, although a planned secondary analysis supported the previously reported decrease of neuronal size in lamina V in bipolar disorder. In summary, our study illustrates a conceptual and methodological approach which may be of value for investigating the differential neuropathological involvement of pyramidal neuron sub-populations. However, we found no clear evidence that the prefrontal neuropathology of schizophrenia or mood disorders preferentially affects SMI32-, N200- or FNP7-immunoreactive pyramidal neurons.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563380     DOI: 10.1016/s0022-3956(03)00075-x

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  15 in total

1.  Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory.

Authors:  Anita J Bechtholt-Gompf; Hali V Walther; Martha A Adams; William A Carlezon; Dost Ongür; Bruce M Cohen
Journal:  Neuropsychopharmacology       Date:  2010-06-09       Impact factor: 7.853

2.  Alcohol dependence-related increase of glial cell density in the anterior cingulate cortex of suicide completers.

Authors:  Christa Hercher; Martin Parent; Cecilia Flores; Lilian Canetti; Gustavo Turecki; Naguib Mechawar
Journal:  J Psychiatry Neurosci       Date:  2009-07       Impact factor: 6.186

Review 3.  Neuropathology of suicide: recent findings and future directions.

Authors:  P-E Lutz; N Mechawar; G Turecki
Journal:  Mol Psychiatry       Date:  2017-07-11       Impact factor: 15.992

4.  Blockade of astrocytic glutamate uptake in the prefrontal cortex induces anhedonia.

Authors:  Catherine S John; Karen L Smith; Ashlee Van't Veer; Heinrich S Gompf; William A Carlezon; Bruce M Cohen; Dost Öngür; Anita J Bechtholt-Gompf
Journal:  Neuropsychopharmacology       Date:  2012-06-27       Impact factor: 7.853

5.  Changes in cortical thickness in the frontal lobes in schizophrenia are a result of thinning of pyramidal cell layers.

Authors:  M R Williams; R Chaudhry; S Perera; R K B Pearce; S R Hirsch; O Ansorge; M Thom; M Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-05-19       Impact factor: 5.270

6.  Unchanged packing density but altered size of neurofilament immunoreactive neurons in the prefrontal cortex in schizophrenia and major depression.

Authors:  Jose Javier Miguel-Hidalgo; Priti Dubey; Qingmei Shao; Craig Stockmeier; Grazyna Rajkowska
Journal:  Schizophr Res       Date:  2005-07-15       Impact factor: 4.939

Review 7.  Dysregulation of the behavioral approach system (BAS) in bipolar spectrum disorders: review of theory and evidence.

Authors:  Snezana Urosević; Lyn Y Abramson; Eddie Harmon-Jones; Lauren B Alloy
Journal:  Clin Psychol Rev       Date:  2008-05-09

8.  Neural stem cell regulation, fibroblast growth factors, and the developmental origins of neuropsychiatric disorders.

Authors:  Hanna E Stevens; Karen M Smith; Brian G Rash; Flora M Vaccarino
Journal:  Front Neurosci       Date:  2010-09-01       Impact factor: 4.677

Review 9.  Biological substrates underpinning diagnosis of major depression.

Authors:  Etienne Sibille; Beverly French
Journal:  Int J Neuropsychopharmacol       Date:  2013-05-14       Impact factor: 5.176

10.  Altered histamine H3 receptor radioligand binding in post-mortem brain samples from subjects with psychiatric diseases.

Authors:  C Y Jin; O Anichtchik; P Panula
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.